At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 60 enrolled
Drug / intervention
Chlorhexidine 2.5 mg +1 moredrug
Likely dose
Chlorhexidine 2.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis
In Brief
A Phase 2 clinical trial evaluating Chlorhexidine 2.5 mg and Placebo chip for Peri-implantitis. Completed, enrolled 60 participants across 2 sites.
Detailed Summary
The purpose of the study is to assess the efficacy and the safety of Chlorhexidine Gluconate chip (Periochip®) versus Placebo Chip in treatment of symptoms in patients with Peri-Implantitis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeri-implantitis
CountriesIsrael
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
First PostedMar 2010
Primary CompletionOct 2011
Study CompletionNov 2011
TodayJul 2026
First PostedMar 3, 2010
Enrollment StartMar 1, 2010
Primary CompletionOct 1, 2011
Study CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 16.3 years ago
Interventions
Chlorhexidine 2.5 mgdrug
Placebo chipdrug